Polymyalgia rheumatica physical examination: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(2 intermediate revisions by one other user not shown)
Line 4: Line 4:


==Overview==
==Overview==
Physical examination of patients with polymyalgia rheumatica reveals limitation of the active and passive range of motion of the affected joint. There is no true muscle weakness. There are no changes in the joints.
Physical examination of patients with polymyalgia rheumatica reveals limitation of the active and passive [[range of motion]] of the affected [[joint]]. There is no true [[muscle weakness]]. There are no changes in the [[Joint|joints]]. [[Ophthalmoscope|Ophthalmoscopic]] exams in patients with polymyalgia rheumatica associated with [[Temporal arteritis|giant cell arteritis]] might be abnormal.


==Physical Examination==
==Physical Examination==
Line 14: Line 14:


=== HEENT ===
=== HEENT ===
* The following findings are associated with cases of polymyalgia rheumatica associated with giant cell arteritis:<ref name="pmid11177002">{{cite journal| author=Casson RJ, Fleming FK, Shaikh A, James B| title=Bilateral ocular ischemic syndrome secondary to giant cell arteritis. | journal=Arch Ophthalmol | year= 2001 | volume= 119 | issue= 2 | pages= 306-7 | pmid=11177002 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11177002  }}</ref><ref name="pmid12972779">{{cite journal| author=Al-Abdulla NA, Kelley JS, Green WR, Miller NR| title=Herpes zoster vasculitis presenting as giant cell arteritis with choroidal infarction. | journal=Retina | year= 2003 | volume= 23 | issue= 4 | pages= 567-9 | pmid=12972779 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12972779  }}</ref>
* The following findings are associated with cases of polymyalgia rheumatica associated with [[Temporal arteritis|giant cell arteritis]]:<ref name="pmid11177002">{{cite journal| author=Casson RJ, Fleming FK, Shaikh A, James B| title=Bilateral ocular ischemic syndrome secondary to giant cell arteritis. | journal=Arch Ophthalmol | year= 2001 | volume= 119 | issue= 2 | pages= 306-7 | pmid=11177002 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11177002  }}</ref><ref name="pmid12972779">{{cite journal| author=Al-Abdulla NA, Kelley JS, Green WR, Miller NR| title=Herpes zoster vasculitis presenting as giant cell arteritis with choroidal infarction. | journal=Retina | year= 2003 | volume= 23 | issue= 4 | pages= 567-9 | pmid=12972779 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12972779  }}</ref>
** [[Ophthalmoscope|Ophthalmoscopic]] exam may be abnormal with findings of sludging of [[blood]] in [[retinal]] [[Arteriole|arterioles]], [[optic disc]] may show chalky white [[pallor]] and [[edema]], with or without [[Splinter hemorrhage|splinter hemorrhages]], [[Posterior ischemic optic neuropathy|posterior ischemic (retrobulbar) optic]] neuropathy, [[central retinal artery]] [[occlusion]], branch of [[Central retinal artery|retinal artery]] [[occlusion]], and [[Choroid|choroidal]] [[ischemia]].
** [[Ophthalmoscope|Ophthalmoscopic]] exam may be abnormal with findings of sludging of [[blood]] in [[retinal]] [[Arteriole|arterioles]], [[optic disc]] may show chalky white [[pallor]] and [[edema]], with or without [[Splinter hemorrhage|splinter hemorrhages]], [[Posterior ischemic optic neuropathy|posterior ischemic (retrobulbar) optic]] neuropathy, [[central retinal artery]] [[occlusion]], branch of [[Central retinal artery|retinal artery]] [[occlusion]], and [[Choroid|choroidal]] [[ischemia]].
** [[Tenderness]] upon [[palpation]] of the [[temporal]] region including [[erythema]], nodularity, and thickening on affected side
** [[Tenderness]] upon [[palpation]] of the [[temporal]] region including [[erythema]], nodularity, and thickening on the affected side
** [[Facial]] [[tenderness]]
** [[Facial]] [[tenderness]]
** Neuro-[[Ophthalmic artery|ophthalmic]] manifestations of temporal arteritis include the following:<ref name="pmid18606086">{{cite journal| author=Borg FA, Salter VL, Dasgupta B| title=Neuro-ophthalmic complications in giant cell arteritis. | journal=Curr Allergy Asthma Rep | year= 2008 | volume= 8 | issue= 4 | pages= 323-30 | pmid=18606086 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18606086  }}</ref>
** Neuro-[[Ophthalmic artery|ophthalmic]] manifestations of [[temporal arteritis]] include the following:<ref name="pmid18606086">{{cite journal| author=Borg FA, Salter VL, Dasgupta B| title=Neuro-ophthalmic complications in giant cell arteritis. | journal=Curr Allergy Asthma Rep | year= 2008 | volume= 8 | issue= 4 | pages= 323-30 | pmid=18606086 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18606086  }}</ref>
*** [[Diplopia]]
*** [[Diplopia]]
*** [[Ptosis]]
*** [[Ptosis]]
Line 32: Line 32:


=== Musculoskeletal ===
=== Musculoskeletal ===
* Proximal joints pain typically in the shoulder and hip joints with active movement<ref name="pmid18640460">{{cite journal| author=Salvarani C, Cantini F, Hunder GG| title=Polymyalgia rheumatica and giant-cell arteritis. | journal=Lancet | year= 2008 | volume= 372 | issue= 9634 | pages= 234-45 | pmid=18640460 | doi=10.1016/S0140-6736(08)61077-6 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18640460  }} </ref>  
* Proximal joints [[tenderness]] typically in the [[shoulder]] and [[Hip|hip joints]] with active movement<ref name="pmid18640460">{{cite journal| author=Salvarani C, Cantini F, Hunder GG| title=Polymyalgia rheumatica and giant-cell arteritis. | journal=Lancet | year= 2008 | volume= 372 | issue= 9634 | pages= 234-45 | pmid=18640460 | doi=10.1016/S0140-6736(08)61077-6 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18640460  }} </ref>  
* Decrease of the active range of motion in the proximal joints  
* Decrease of the active [[range of motion]] in the proximal [[Joint|joints]]
* Normal muscle strength
* Normal [[muscle]] strength
* No muscle atrophy  
* No [[muscle atrophy]]
* Transient synovitis of the knee, wrist, and sternoclavicular joints
* Transient [[synovitis]] of the [[knee]], [[wrist]], and [[Sternoclavicular joint|sternoclavicular joints]]
* Arthritis in some cases  
* [[Arthritis]] in some cases  


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


{{WH}}
[[Category:Medicine]]
{{WS}}
[[Category:Disease]]
[[Category:Rheumatology]]
[[Category:Rheumatology]]
[[Category:Up-To-Date]]

Latest revision as of 23:47, 29 July 2020

Polymyalgia Rheumatica Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Polymyalgia rheumatica from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Polymyalgia rheumatica physical examination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polymyalgia rheumatica physical examination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polymyalgia rheumatica physical examination

CDC on Polymyalgia rheumatica physical examination

Polymyalgia rheumatica physical examination in the news

Blogs on Polymyalgia rheumatica physical examination

Directions to Hospitals Treating Polymyalgia rheumatica

Risk calculators and risk factors for Polymyalgia rheumatica physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

Physical examination of patients with polymyalgia rheumatica reveals limitation of the active and passive range of motion of the affected joint. There is no true muscle weakness. There are no changes in the joints. Ophthalmoscopic exams in patients with polymyalgia rheumatica associated with giant cell arteritis might be abnormal.

Physical Examination

Appearance of the patients

  • Patients with polymyalgia rheumatica usually appear in pain.

Vital signs

  • Hypothermia

HEENT

Lungs

  • Pulmonary examination of patients with polymylagia rheumatica is usually normal.

Heart

  • Cardiovascular examination of patients with polymylagia rheumatica is usually normal.

Musculoskeletal

References

  1. Casson RJ, Fleming FK, Shaikh A, James B (2001). "Bilateral ocular ischemic syndrome secondary to giant cell arteritis". Arch Ophthalmol. 119 (2): 306–7. PMID 11177002.
  2. Al-Abdulla NA, Kelley JS, Green WR, Miller NR (2003). "Herpes zoster vasculitis presenting as giant cell arteritis with choroidal infarction". Retina. 23 (4): 567–9. PMID 12972779.
  3. Borg FA, Salter VL, Dasgupta B (2008). "Neuro-ophthalmic complications in giant cell arteritis". Curr Allergy Asthma Rep. 8 (4): 323–30. PMID 18606086.
  4. Salvarani C, Cantini F, Hunder GG (2008). "Polymyalgia rheumatica and giant-cell arteritis". Lancet. 372 (9634): 234–45. doi:10.1016/S0140-6736(08)61077-6. PMID 18640460.